ClassID:

96849

C07K14/34 - CPC Classification

Classification description:

Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Corynebacterium (G)

Recent Application in this class:
#1
20260132174
2026-05-14

RIBONUCLEASE ACTIVITY REGULATOR PROTEIN VARIANT AND METHOD OF PRODUCING L-VALINE USING THE SAME

#2
20260109737
2026-04-23

ANTI-CRISPR DELIVERY COMPOSITIONS AND METHODS

#3
20260102480
2026-04-16

DIPHTHERIA-TETANUS-PERTUSSIS COMPOUND ADJUVANT COMBINED VACCINE

#4
20260071227
2026-03-12

METHOD FOR SECRETORY PRODUCTION OF PROTEINS

#5
20260042853
2026-02-12

BISPECIFIC IMMUNOTOXINS TARGETING HUMAN CD25+CCR4+ TUMORS AND REGULATORY T-CELLS

#6
20260008823
2026-01-08

CRM197 PROTEIN EXPRESSION METHOD

#7
20260002187
2026-01-01

AUTOMATED PERIPLASMIC EXTRACTION

#8
20250381279
2025-12-18

CYTOTOXIN-CCL8 PEPTIDE CONSTRUCTS AND USES THEREOF

#9
20250368692
2025-12-04

E. COLI FOR THE PRODUCTION OF DIPHTHERIA TOXIN POLYPEPTIDES

#10
20250326804
2025-10-23

METHOD FOR PRODUCING A PERIPLASMIC FORM OF THE PROTEIN CRM197

#11
20250326803
2025-10-23

GLXR PROTEIN VARIANT OR THREONINE PRODUCTION METHOD USING SAME

#12
20250320263
2025-10-16

NOVEL GLUTAMATE GLUCONATE REPRESSOR VARIANT AND METHOD FOR PRODUCING L-ARGININE USING SAME

#13
20250320262
2025-10-16

NOVEL VARIANT REGULATOR OF ACETATE METABOLISM A AND METHOD OF PRODUCING L-BRANCHED-CHAIN AMINO ACID USING THE SAME

#14
20250304979
2025-10-02

RECOMBINANT STRAIN WITH MODIFIED GENE BBD29_09525 FOR PRODUCING L-GLUTAMIC ACID, AND METHOD FOR CONSTRUCTING THE SAME AND USE THEREOF

#15
20250277226
2025-09-04

IMPROVED BIOTECHNOLOGICAL METHOD FOR PRODUCING GUANIDINO ACETIC ACID (GAA) BY INACTIVATION OF AN AMINO ACID EXPORTER

#16
20250230200
2025-07-17

LYSE VARIANT AND METHOD FOR PRODUCING L-ARGININE BY USING SAME

#17
20250223324
2025-07-10

DIPHTHERIA-BASED INTRANEURAL DELIVERY VEHICLES AND PRODUCTION PROCESSES THEREOF

#18
20250101473
2025-03-27

RECOMBINANT MICROORGANISM, METHOD FOR CONSTRUCTING SAME AND USE THEREOF

#19
20250101443
2025-03-27

MICROORGANISM HAVING WEAKENED ACTIVITY OF LACI FAMILY DNA-BINDING TRANSCRIPTIONAL REGULATOR, AND L-GLUTAMIC ACID PRODUCTION METHOD USING SAME

#20
20240401066
2024-12-05

STRAIN FOR PRODUCING HIGH CONCENTRATION L-GLUTAMIC ACID AND METHOD FOR PRODUCING L-GLUTAMIC ACID USING THE SAME

#21
20240358823
2024-10-31

CONJUGATED VACCINE CARRIER PROTEINS

#22
20240294866
2024-09-05

RECOMBINANT STRAIN WITH MODIFIED GENE BBD29_04920 FOR PRODUCING L-GLUTAMIC ACID, AND METHOD FOR CONSTRUCTING THE SAME AND USE THEREOF

#23
20240285789
2024-08-29

Compositions and Methods for Killing PD-1 Positive Cells

#24
20240271169
2024-08-15

Method for the fermentative production of L-lysine using strains expressing modified gluconate repressor proteins GntR1 and GntR2

#25
20240254170
2024-08-01

COMPOSITIONS AND METHODS FOR THE ENCAPSULATION AND SCALABLE DELIVERY OF AGROCHEMICALS

#26
20240226262
2024-07-11

Composition for Oral or Nasal Delivery of Tetanus, Diphtheria, and Pertussis Vaccine alone or in combination using Neurotoxin Associated Proteins

#27
20240199706
2024-06-20

IMMUNOMODULATORY COMPLEX AND USES THEREOF FOR THERAPY

#28
20240180974
2024-06-06

MICROORGANISMS PROGRAMMED TO PRODUCE IMMUNE MODULATORS AND ANTI-CANCER THERAPEUTICS IN TUMOR CELLS

#29
20240131137
2024-04-25

Composition for oral or nasal delivery of tetanus, diphtheria, and pertussis vaccine alone or in combination using neurotoxin associated proteins

#30
20240076701
2024-03-07

RECOMBINANT STRAIN WITH MODIFIED GENE BBD29_14900, AND METHOD FOR CONSTRUCTING THE SAME AND USE THEREOF

#31
20240076325
2024-03-07

Vaccines targeting Pseudomonas aeruginosa

#32
20240067999
2024-02-29

RECOMBINANT STRAIN WITH MODIFIED GENE BBD29_11265 FOR PRODUCING L-GLUTAMIC ACID, AND METHOD FOR CONSTRUCTING THE SAME AND USE THEREOF

#33
20240067998
2024-02-29

STRAIN HAVING ENHANCED L-GLUTAMIC ACID PRODUCTIVITY, CONSTRUCTION METHOD THEREFOR AND APPLICATION THEREOF

#34
20240058438
2024-02-22

Hepatitis C virus immunogenic compositions and methods of use thereof

#35
20240052386
2024-02-15

PROTEIN HAVING L-PROLINE EFFLUX FUNCTION, AND USE THEREOF

#36
20240000926
2024-01-04

PURIFICATION PROCESSES FOR POLYSACCHARIDES AND POLYPEPTIDE CONJUGATES THEREOF

#37
20230357330
2023-11-09

Compositions and methods for the encapsulation and scalable delivery of agrochemicals

#38
20230331788
2023-10-19

deficient in Lon and SulA for gene targeting

#39
20230323412
2023-10-12

RECOMBINANT STRAIN FOR PRODUCING L-AMINO ACID AND CONSTRUCTION METHOD AND USE THEREOF

#40
20230303718
2023-09-28

Modified Antibody

#41
20230295645
2023-09-21

RECOMBINANT STRAIN PRODUCING L-LYSINE AND CONSTRUCTION METHODS THEREFOR AND USE THEREOF

#42
20230287472
2023-09-14

Reduced genome lacking toxin-antitoxin genes

#43
20230272441
2023-08-31

NOVEL L-TYROSINE-EXPORTING PROTEIN VARIANT AND METHOD FOR PRODUCING L-TYROSINE USING THE SAME

#44
20230248839
2023-08-10

IMMUNOGENIC COMPOSITIONS

#45
20230242952
2023-08-03

Microorganism that produces lysine and method for producing lysine

#46
20230227524
2023-07-20

Polypeptide and method of producing IMP using the same

#47
20230203106
2023-06-29

NOVEL ACETOHYDROXY ACID SYNTHASE VARIANT AND MICROORGANISM INCLUDING THE SAME

#48
20230203091
2023-06-29

Glycoconjugation process

#49
20230192780
2023-06-22

Polypeptide and method of producing IMP using the same

#50
20230183307
2023-06-15

Methods of producing aggregate-free monomeric diphtheria toxin fusion proteins and therapeutic uses

#51
20230136217
2023-05-04

MUTANT OF CORYNEBACTERIUM GLUTAMICUM WITH ENHANCED L-GLUTAMIC ACID PRODUCTIVITY AND METHOD FOR PREPARING L-GLUTAMIC ACID USING THE SAME

#52
20230131650
2023-04-27

IMMUNOGENIC CONJUGATE INTENDED TO INDUCE AN IMMUNE RESPONSE DIRECTED AGAINST INTERLEUKIN-6

#53
20230097992
2023-03-30

BIVALENT EGF FUSION TOXINS

#54
20230086419
2023-03-23

MICROORGANISMS WITH ENHANCED L-BRANCHED-CHAIN AMINO ACIDS PRODUCTIVITY AND METHOD FOR PRODUCING L-BRANCHED-CHAIN AMINO ACIDS USING THE SAME

#55
20230072150
2023-03-09

MICROORGANISM COMPRISING VARIANT LYSE AND METHOD OF L-AMINO ACID PRODUCTION USING SAME

#56
20230048561
2023-02-16

Modified Antibody

#57
20230048492
2023-02-16

Adeno-Associated Viral (AAV) Vectors for Tissue-Targeted Expression of Therapeutic Genes

#58
20230018689
2023-01-19

CRM197 protein expression

#59
20220380821
2022-12-01

Microorganism producing purine nucleotide and method of producing purine nucleotide using the same

#60
20220348616
2022-11-03

Polypeptide and method of producing IMP using the same

#61
20220348615
2022-11-03

PRODUCTION OF BACTERIOCINS

#62
20220315964
2022-10-06

Method of producing sulfur-containing amino acid or derivative thereof

#63
20220315963
2022-10-06

METHOD OF PRODUCING SULFUR-CONTAINING AMINO ACID OR DERIVATIVE THEREOF

#64
20220288160
2022-09-15

FUSION PROTEINS AND USES THEREOF

#65
20220281928
2022-09-08

CRM197 PROTEIN EXPRESSION METHOD

#66
20220235108
2022-07-28

Methods and compositions based on diphtheria toxin-interleukin-3 conjugates

#67
20220213151
2022-07-07

COMPOSITIONS AND METHODS FOR TREATMENT OF DISTENTABLE TISSUES

#68
20220205003
2022-06-30

MICROORGANISM WITH ENHANCED L-HISTIDINE PRODUCTION CAPACITY AND METHOD FOR PRODUCING HISTIDINE BY USING SAME

#69
20220204579
2022-06-30

METHODS OF PRODUCING AGGREGATE-FREE MONOMERIC DIPHTHERIA TOXIN FUSION PROTEINS AND THERAPEUTIC USES

#70
20220170059
2022-06-02

MICROORGANISM HAVING ENHANCED L-THREONINE PRODUCING ABILITY AND METHOD FOR PRODUCING THREONINE USING THE SAME

#71
20220127368
2022-04-28

BISPECIFIC IMMUNOTOXINS TARGETING HUMAN CD25+CCR4+ TUMORS AND REGULATORY T-CELLS

#72
20220106366
2022-04-07

RamA transcription factor mutant for promoting production of N-acetylglucosamine and use thereof

#73
20220090101
2022-03-24

Transcription factor SugR coding gene, and use thereof in production of N-acetylglucosamine

#74
20220054632
2022-02-24

MODIFIED CARRIER PROTEINS FOR O-LINKED GLYCOSYLATION

#75
20220031827
2022-02-03

Tetanus toxoid and CCL3 improve DC vaccines

#76
20220025361
2022-01-27

Polypeptide and method of producing IMP using the same

#77
20210395324
2021-12-23

Multi-level specific targeting of cancer cells

#78
20210371453
2021-12-02

Glycoconjugation process

#79
20210348174
2021-11-11

Production of soluble recombinant proteins without N-terminal methionine in

#80
20210317203
2021-10-14

Immunotoxin for treating cancer

#81
20210214753
2021-07-15

Recombinant having 1,3-PDO productivity and reduced 3-HP productivity, and method for producing 1,3-PDO by using same

#82
20210170018
2021-06-10

Hepatitis C virus immunogenic compositions and methods of use thereof

#83
20210148923
2021-05-20

METHODS AND KITS FOR IDENTIFYING A PROTEIN ASSOCIATED WITH RECEPTOR-LIGAND INTERACTIONS

#84
20210139937
2021-05-13

Microorganism of genus producing L-arginine and method for producing L-arginine using the same

#85
20210040203
2021-02-11

Immunotoxin for treating cancer

#86
20210032284
2021-02-04

METHOD FOR EFFICIENTLY RECOVERING AND PURIFYING ACTIVE CRM197 FROM INSOLUBLE CRM197 PROTEIN EXPRESSED IN INCLUSION BODY

#87
20210024941
2021-01-28

METHOD FOR SECRETORY PRODUCTION OF PROTEIN

#88
20200407405
2020-12-31

Split-immunotoxins for boosting oncolytic virus toxicity

#89
20200405871
2020-12-31

Immunogenic compositions

#90
20200377558
2020-12-03

Polypeptide and method of producing IMP using the same

#91
20200377557
2020-12-03

Polypeptide and method of producing IMP using the same

#92
20200362374
2020-11-19

Microorganism of the genus producing L-amino acids and a method for producing L-amino acids using the same

#93
20200331973
2020-10-22

NUCLEIC ACID ENCODING CRM197 AND PROCESS FOR IMPROVED EXPRESSION THEREOF

#94
20200331959
2020-10-22

Glycoconjugation process

#95
20200318150
2020-10-08

Methods and compositions for improved expression of recombinant proteins

#96
20200277341
2020-09-03

Method for high level production of CRM

#97
20200270658
2020-08-27

Recombinant microorganism having enhanced ability to produce heme, coproporphyrin III, and uroporphyrin III, and method for producing heme, coproporphyrin III, and uroporphyrin III using same

#98
20200255483
2020-08-13

Delivery of structurally diverse polypeptide cargo into mammalian cells by a bacterial toxin

#99
20200239529
2020-07-30

NANOSTRUCTURED PROTEINS AND USES THEREOF

#100
20200231635
2020-07-23

Systems and methods for the production of diphtheria toxin polypeptides

#101
20200216872
2020-07-09

Production of soluble recombinant protein without n-terminal methionine

#102
20200216798
2020-07-09

Materials and methods for extended continuous flow fermentation of reduced genome bacteria

#103
20200208182
2020-07-02

Modified polypeptide having an activity of ornithine-based product exporter and method for producing ornithine-based product using cells expressing the polypeptide

#104
20200207804
2020-07-02

Purification of CRM 197 from bacteria

#105
20200157166
2020-05-21

Methods of producing aggregate-free monomeric diphtheria toxin fusion proteins and therapeutic uses

#106
20200138906
2020-05-07

METHOD OF TREATING A BLADDER CANCER USING A CHIMERIC EGF-TARGETED BACTERIAL TOXIN

#107
20200113177
2020-04-16

Compositions and methods for the encapsulation and scalable delivery of agrochemicals

#108
20200095302
2020-03-26

Multi-level specific targeting of cancer cells

#109
20200061179
2020-02-27

Polysaccharide-protein conjugates utilizing diphtheria toxin fragment B as a carrier

#110
20200054739
2020-02-20

Conjugated vaccine carrier proteins

#111
20200048640
2020-02-13

Method of producing 2′-fucosyllactose using recombinant

#112
20190352344
2019-11-21

Method for expressing and purifying soluble protein of CRM197

#113
20190330281
2019-10-31

Vaccines targeting

#114
20190330265
2019-10-31

Glycoconjugation process

#115
20190322708
2019-10-24

EXPRESSION SYSTEM

#116
20190284595
2019-09-19

Polypeptide and method of producing IMP using the same

#117
20190284591
2019-09-19

Mutant microorganism for producing L-cysteine and method for producing L-cysteine using same

#118
20190241622
2019-08-08

Protein secretory production method

#119
20190231867
2019-08-01

Hepatitis C virus immunogenic compositions and methods of use thereof

#120
20190203236
2019-07-04

Method of producing D-xylonate and coryneform bacterium

#121
20190195894
2019-06-27

Microbial-based biosensors

#122
20190194769
2019-06-27

Genetic perturbation of the RNA degradosome protein complex

#123
20190194280
2019-06-27

PEPTIDE VACCINE FOR PREVENTION AND IMMUNOTHERAPY OF DEMENTIA OF THE ALZHEIMER'S TYPE

#124
20190169251
2019-06-06

Methods for inhibiting hematopoietic tumor cells with diphtheria tokin-interleukin-3 conjugates

#125
20190160115
2019-05-30

Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cells

#126
20190153057
2019-05-23

Multi-level specific targeting of cancer cells

#127
20190119709
2019-04-25

Microorganisms for producing diamine and process for producing diamine using them

#128
20190085340
2019-03-21

Method for the fermentative production of L-amino acids

#129
20190076518
2019-03-14

Composition for oral or nasal delivery of tetanus, diphtheria, and pertussis vaccine alone or in combination using neurotoxin associated proteins

#130
20190071472
2019-03-07

Methods of producing aggregate-free monomeric diphtheria toxin fusion proteins and therapeutic uses

#131
20190032063
2019-01-31

Expression and purification of CRM proteins and related proteins, and protein domains

#132
20180334515
2018-11-22

Methods for making saccharide-protein glycoconjugates

#133
20180298389
2018-10-18

Corynebacterium glutamicum for use in producing 2′-fucosyllactose

#134
20180273920
2018-09-27

Deimmunized therapeutic compositions and methods

#135
20180258452
2018-09-13

sp. microorganisms having l-lysine-producing ability and l-lysine producing method using same

#136
20180258385
2018-09-13

Signal peptide, L-glutamic acid synthesized using konjac flour and methods of using same

#137
20180258146
2018-09-13

EXPRESSION SYSTEM

#138
20180251499
2018-09-06

sp. microorganisms having L-lysine-producing ability and method for producing L-lysine using same

#139
20180244739
2018-08-30

PEPTIDE VACCINE FOR PREVENTION AND IMMUNOTHERAPY OF DEMENTIA OF THE ALZHEIMER'S TYPE

#140
20180237807
2018-08-23

METHOD OF SCREENING GENE FOR 1,4-BDO PRODUCTION

#141
20180236054
2018-08-23

Tetanus toxoid and CCL3 improve DC vaccines

#142
20180195097
2018-07-12

Microorganism producing L-lysine and method for producing L-lysine using the same

#143
20180100173
2018-04-12

Gluconate repressor variant, microorganism containing the same producing L-lysine, and method for producing L-lysine

#144
20180094285
2018-04-05

Method for producing L-amino acid

#145
20180087018
2018-03-29

Materials and methods for extended continuous flow fermentation of reduced genome bacteria

#146
20180080033
2018-03-22

Delivery of structurally diverse polypeptide cargo into mammalian cells by a bacterial toxin

#147
20180037918
2018-02-08

Method for secretory production of protein

#148
20180037615
2018-02-08

Microorganism with enhanced L-lysine producibility and method for producing L-lysine using the same

#149
20180022788
2018-01-25

Methods and compositions based on diphtheria toxin-interleukin-3 conjugates

#150
20180009851
2018-01-11

Compositions and methods for peptide expression and purification using a type III secretion system

#151
20180002394
2018-01-04

Nucleic acids encoding a fusion protein useful for multi-level specific targeting of cancer cells

#152
20170319657
2017-11-09

Method of treating a bladder cancer using a chimeric EGF-targeted bacterial toxin

#153
20170306302
2017-10-26

Codon optimized polynucleotide for high level expression of CRM197

#154
20170283471
2017-10-05

MODIFIED MICROBIAL TOXIN RECEPTOR FOR DELIVERING AGENTS INTO CELLS

#155
20170275389
2017-09-28

Glycan conjugates and use thereof

#156
20170246313
2017-08-31

Process of conjugation and novel synthetic oligosaccharide-protein conjugates obtained thereof

#157
20170218060
2017-08-03

Polypeptide for binding to complement protein C5A, and use of same

#158
20170204439
2017-07-20

Microorganism having improved L-lysine productivity and method for producing L-lysine using same

#159
20170137475
2017-05-18

Expression system

#160
20170121743
2017-05-04

Method for producing L-amino acid of glutamate family

#161
20170081373
2017-03-23

Targeting of chondroitin sulfate glycans

#162
20170073379
2017-03-16

Enhanced production of recombinant CRM197 in

#163
20170044581
2017-02-16

Microorganisms for producing diamine and process for producing diamine using them

#164
20170044220
2017-02-16

EXPRESSION OF TRIPLE-HELICAL COLLAGEN-LIKE PRODUCTS IN E.COLI

#165
20170029474
2017-02-02

POLYPEPTIDE AND ANTI-TUMOR AGENT

#166
20170016905
2017-01-19

Targeting of chondroitin sulfate glycans

#167
20170015713
2017-01-19

Fusion protein comprising diphtheria toxin non-toxic mutant CRM197 or fragment thereof

#168
20170014506
2017-01-19

Fusion protein comprising diphtheria toxin non-toxic mutant CRM197 or fragment thereof

#169
20170002365
2017-01-05

Recombinant microorganisms of with L-threonine productivity and method of producing L-threonine using the same

#170
20160362458
2016-12-15

Modified microbial toxin receptor for delivering agents into cells

#171
20160355830
2016-12-08

microorganism with improved ability to produce L-lysine and method for producing L-lysine using the same

#172
20160333057
2016-11-17

Expression and purification of CRM197 and related proteins

#173
20160297895
2016-10-13

Methods for making saccharide-protein glycoconjugates

#174
20160271240
2016-09-22

Tetanus toxoid and CCL3 improve DC vaccines

#175
20160244490
2016-08-25

Microorganism and Method for the Fermentative Production of an Organic-Chemical Compound

#176
20160222394
2016-08-04

Method for producing target substance

#177
20160222055
2016-08-04

Method for producing protein by precipitation

#178
20160208292
2016-07-21

Method of screening gene for 1,4-BDO production

#179
20160206732
2016-07-21

EPITOPE VACCINE FOR LOW IMMUNOGENIC PROTEIN AND PREPARING METHOD AND USAGE THEREOF

#180
20160199507
2016-07-14

Methods for treating cancer using an immunotoxin

#181
20160177352
2016-06-23

Microorganism for methionine production with improved methionine synthase activity and methionine efflux

#182
20160145661
2016-05-26

Microorganism of the genus with enhanced ability to produce L-arginine and method for producing L-arginine using the same

#183
20160068581
2016-03-10

PEPTIDE VACCINE FOR PREVENTION AND IMMUNOTHERAPY OF DEMENTIA OF THE ALZHEIMER'S TYPE

#184
20160060640
2016-03-03

Coryneform bacterium and method for producing heterologous fusion proteins

#185
20160039946
2016-02-11

Modified antibody

#186
20160039890
2016-02-11

INTRAOCULAR ANGIOGENESIS INHIBITOR AND USES THEREOF

#187
20160024167
2016-01-28

Methods and compositions based on diphtheria toxin-interleukin-3 conjugates

#188
20160009768
2016-01-14

Modified toxins

#189
20150376245
2015-12-31

Methods and compositions relating to CRM197

#190
20150328328
2015-11-19

Glycoconjugation process

#191
20150307907
2015-10-29

Method for producing L-amino acid using microorganism having increased phosphate transporter activity

#192
20150275239
2015-10-01

Genetically engineered bacterial cell having enhanced activity of GlnD or GlnK and method of producing organic acid by using the same

#193
20150258216
2015-09-17

MIR-21 PROMOTER DRIVEN TARGETED CANCER THERAPY

#194
20150225466
2015-08-13

Compositions and methods for peptide expression and purification using a type III secretion system

#195
20150203557
2015-07-23

Multi-level specific targeting of cancer cells

#196
20150184215
2015-07-02

DEVELOPMENT OF THE SOLUBLE RECOMBINANT CRM197 PRODUCTION BY E. COLI

#197
20150157708
2015-06-11

Conjugates for the Prevention or Treatment of Nicotine Addiction

#198
20150125919
2015-05-07

MICROORGANISM WITH INCREASED IRON-REGULATED ABC TRANSPORTER ACTIVITY AND METHOD OF PRODUCING HYDROXYCARBOXYLIC ACID BY USING THE MICROORGANISM

#199
20150118260
2015-04-30

Recombinant cytotoxic T-lymphocyte-associated protein 4 (CTLA4)

#200
20150104837
2015-04-16

Genes encoding biofilm formation inhibitory proteins and a method for producing L-lysine using a bacterial strain with the inactivated genes

#201
20150093432
2015-04-02

COMPOSITION

#202
20150093431
2015-04-02

COMPOSITIONS

#203
20150051146
2015-02-19

HB-EGF inhibitor derived from the R domain of diphtheria toxin for the treatment of diseases associated with the activation of the HB-EGF/EGFR pathway

#204
20150004099
2015-01-01

Targeting of chondroitin sulfate glycans

#205
20140329998
2014-11-06

Methods for making saccharide-protein glycoconjugates

#206
20140296324
2014-10-02

Vectors harboring toxic genes, methods and uses therefor

#207
20140255996
2014-09-11

Method for secretory production of protein

#208
20140234901
2014-08-21

Method for secretory production of protein

#209
20140220637
2014-08-07

Method for secretory production of protein

#210
20140178417
2014-06-26

Methods for treating cancer using an immunotoxin

#211
20140147889
2014-05-29

Promoter of Corynebacteria

#212
20140134682
2014-05-15

Processes and recombinant microorganisms for the production of cadaverine

#213
20140127787
2014-05-08

Process for preparing L-amino acids

#214
20140086949
2014-03-27

Ghrelin mimetic polypeptide hapten immunoconjugates having improved solubility and immunogenicity and methods of use thereof

#215
20140051132
2014-02-20

Method for producing an L-amino acid belonging to the glutamate family, using a coryneform bacterium

#216
20140051093
2014-02-20

High level expression of recombinant toxin proteins

#217
20140050758
2014-02-20

Fermentation process

#218
20140030773
2014-01-30

Modified microorganism for high efficient production of 1,4-butanediol

#219
20140004577
2014-01-02

Microorganisms for producing putrescine and method for producing putrescine using same

#220
20130344545
2013-12-26

Microorganisms having improved ornithine-producing ability and method for producing ornithine using the same

#221
20130344104
2013-12-26

OLIGOSACCHARIDES AND OLIGOSACCHARIDE-PROTEIN CONJUGATES DERIVED FROM CLOSTRIDIUM DIFFICILE POLYSACCHARIDE PS-II, METHODS OF SYNTHESIS AND USES THEREOF, IN PARTICULAR AS A VACCINE

#222
20130344103
2013-12-26

Conjugation process

#223
20130338345
2013-12-19

Purification of Diphtheria Toxoid

#224
20130315860
2013-11-28

Methods and compositions based on diphtheria toxin-interleukin-3 conjugates

#225
20130243802
2013-09-19

Polypeptides with affinity for heat shock proteins (HSPS) and HSP associated complexes (HACS) and their use in diagnosis and therapy

#226
20130211049
2013-08-15

Immunotoxin fusion proteins and means for expression thereof

#227
20130164257
2013-06-27

Compounds useful for multi-level specific targeting of cancer cells

#228
20130143316
2013-06-06

Nucleic acids molecule encoding the polypeptide for treating virus-induced cancer

#229
20130143268
2013-06-06

Method of producing the polypeptide for treating virus-induced cancer

#230
20130122040
2013-05-16

Fermentation media free of animal-derived components for production of diphtheria toxoids suitable for human vaccine use

#231
20120289688
2012-11-15

Expression system

#232
20120288523
2012-11-15

ADMINISTRATION ROUTE FOR A COMPOSITION TO PROTECT AN ANIMAL AGAINST RHODOCOCCUS EQUI

#233
20120258490
2012-10-11

Process for producing dipeptides or dipeptide derivatives

#234
20120252075
2012-10-04

Microorganism and method for the fermentative production of an organic-chemical compound

#235
20120232010
2012-09-13

Compositions and methods for treating bladder cancer

#236
20120171242
2012-07-05

Modified antibody

#237
20120149650
2012-06-14

Diphtheria toxin variant

#238
20120128727
2012-05-24

BACTERIAL EXPRESSION OF AN ARTIFICIAL GENE FOR THE PRODUCTION OF CRM197 AND ITS DERIVATIVES

#239
20120128700
2012-05-24

CONSTRUCTS FOR DELIVERY OF THERAPEUTIC AGENTS TO NEURONAL CELLS

#240
20120116053
2012-05-10

Expression of triple-helical collagen-like products in

#241
20120077965
2012-03-29

Non-aqueous synthesis of polysaccharide-protein conjugates for vaccines

#242
20120070456
2012-03-22

POLYPEPTIDE CARRIER PROTEIN

#243
20120065251
2012-03-15

MIR-21 promoter driven targeted cancer therapy

#244
20120034669
2012-02-09

PROCESS FOR PRODUCING USEFUL SUBSTANCE

#245
20110300174
2011-12-08

Conjugates for the prevention or treatment of nicotine addiction

#246
20110300099
2011-12-08

Multi-level specific targeting of cancer cells with IL-13

#247
20110287443
2011-11-24

High level expression of recombinant toxin proteins

#248
20110274749
2011-11-10

Methods and compositions for targeting agents into and across the blood-brain barrier and other endothelial cell microvascular barriers

#249
20110263834
2011-10-27

Simple method for simultaneous removal of multiple impurities from culture supernatants to ultralow levels

#250
20110244528
2011-10-06

Process for producing useful substance

#251
20110229937
2011-09-22

Method for producing methionine using a microorganism with reduced expression activity of a negative regulator of methionine biosynthesis

#252
20110171679
2011-07-14

L-glutamic acid-producing microorganism and a method for producing L-glutamic acid

#253
20110098346
2011-04-28

NUCLEIC ACID MOLECULE AND METHOD OF TARGETING GENE EXPRESSION TO GLIOMAS

#254
20110097359
2011-04-28

Production of diphtheria toxin

#255
20110086416
2011-04-14

Immunotoxin fusion proteins and means for expression thereof

#256
20110045549
2011-02-24

Method of producing lysine by culturing a host cell expressing a polynucleotide encoding a feedback resistant aspartokinase from

#257
20100286384
2010-11-11

Replikin peptides in rapid replication of glioma cells and in influenza epidemics

#258
20100278860
2010-11-04

System and method for identifying complex patterns of amino acids

#259
20100261233
2010-10-14

L-lysine-producing corynebacteria and process for the preparation of L-lysine

#260
20100255511
2010-10-07

Immunological tests for the presence of bacteria which make use of antibodies obtained using a specific method

#261
20100249039
2010-09-30

Methods for treating cancer using an immunotoxin

#262
20100240876
2010-09-23

REPLIKINS AND METHODS OF IDENTIFYING REPLIKIN-CONTAINING SEQUENCES

#263
20100215680
2010-08-26

REPLIKIN PEPTIDES AND ANTIBODIES THEREFOR

#264
20100196379
2010-08-05

Group B polypeptides nucleic acids and therapeutic compositions and vaccines thereof

#265
20100150954
2010-06-17

Vaccines against influenza virus

#266
20100129864
2010-05-27

Novel Bacteriocins, Transport and Vector System and Method of Use Thereof

#267
20100068769
2010-03-18

L-glutamic acid-producing microorganism and a method for producing L-glutamic acid

#268
20100055761
2010-03-04

Methods, compositions, and kits for the selective activation of protoxins through combinatorial targeting

#269
20100047900
2010-02-25

L-lysine-inducible promoter

#270
20100047881
2010-02-25

Microorganisms with Deregulated Vitamin B12 System

#271
20090325242
2009-12-31

Alleles of the zwf gene from coryneform bacteria

#272
20090311758
2009-12-17

Process for preparing L-amino acids

#273
20090270319
2009-10-29

Pharmaceutical use of protein molecules immunologically correlated to diptheria toxin

#274
20090269361
2009-10-29

Constructs for delivery of therapeutic agents to neuronal cells

#275
20090269333
2009-10-29

REPLIKIN PEPTIDES IN RAPID REPLICATION OF GLIOMA CELLS AND IN INFLUENZA EPIDEMICS

#276
20090258402
2009-10-15

L-glutamic acid producing bacterium and a method for production of L-glutamic acid

#277
20090246836
2009-10-01

Pgro expression units

#278
20090232767
2009-09-17

Methods for treating acute myeloid leukemia with diphtheria toxin-interleukin-3 conjugates

#279
20090227770
2009-09-10

Polypeptide carrier protein

#280
20090226981
2009-09-10

L-glutamic acid-producing microorganism and a method for producing L-glutamic acid

#281
20090221500
2009-09-03

Modified toxins

#282
20090221027
2009-09-03

Use of a bacillus meti gene to improve methionine production in microorganisms

#283
20090191189
2009-07-30

Replikin peptides in rapid replication of glioma cells and in influenza epidemics

#284
20090170170
2009-07-02

P2-10 expression units

#285
20090156502
2009-06-18

Diphtheria toxin variant

#286
20090137778
2009-05-28

REPLIKIN PEPTIDES AND ANTIBODIES THEREFORE

#287
20090075882
2009-03-19

RECEPTOR-MEDIATED UPTAKE OF AN EXTRACELLULAR BCL-XL FUSION PROTEIN INHIBITS APOPTOSIS

#288
20090041797
2009-02-12

Modified toxins

#289
20090029356
2009-01-29

Corynebacterium glutamicum genes encoding novel proteins

#290
20090010966
2009-01-08

MODIFIED DIPHTHERIA TOXINS

#291
20090004745
2009-01-01

P19 Expression Units

#292
20080318286
2008-12-25

P1-35 Expression Units

#293
20080306003
2008-12-11

Viral/bacterial toxin polypeptides and methods of using same

#294
20080280333
2008-11-13

Use of the repressor glxR for the synthesis of lysine in corynebacterium glutamicum

#295
20080275214
2008-11-06

Replikins and methods of identifying replikin-containing sequences

#296
20080268502
2008-10-30

Multiple promoters and the use thereof for gene expression

#297
20080261269
2008-10-23

Alleles of the oxyR gene from coryneform bacteria

#298
20080213179
2008-09-04

Methods and compositions for targeting agents into and across the blood-barrier and other endothelial cell microvascular barriers

#299
20080206269
2008-08-28

Bacterial pheromones and uses thereof

#300
20080193475
2008-08-14

Fermentation Process for the Production of Diphtheria Toxin